The efficacy of botox in treating peyronie disease; a clinnical trial

The efficacy of botox in treating peyronie disease; a clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201203129274N1

Enrollment

Registered

2012-05-30

Start date

2011-07-27

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peyronie disease. induratio penis plastica

Interventions

patients were treated with 100 unith of botox in 5cc of normal saline (intralesional ).

Treatment - Drugs

patients were treated with 100 unith of botox in 5cc of normal saline (intralesional )

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Inclusion criterion: stable peyronie plaque. Exclusion criteria : active phase of peyronie disease; less than 1 year history of peyronie disease and allegy to botox

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Size of plaque. Timepoint: preinjection and postinjection(8,16 weeks later ). Method of measurement: with sonography , milimeter.;Penile curvature. Timepoint: preinjection and postinjection(8,16 weeks later ). Method of measurement: with photography , degree.;Imprvement of sexual intercourse. Timepoint: preinjection and postinjection(8,16 weeks later ). Method of measurement: clinical.	—

Secondary

Measure	Time frame
Side effect. Timepoint: preinjection and post injection (8 ,16 weeks later ). Method of measurement: clinical.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mehdi Yazdinejad

Ahvaz Jundishapour University of Medical Sciences

yazdi.mehdi57@yahoo.com+98 61 1416 4950

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026